Cholestasis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
420
|
15
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
response to ACE inhibitor
|
phenotype |
|
Organism Function
|
15
|
26
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Glomerular Filtration Rate
|
phenotype |
|
Diagnostic Procedure
|
399
|
1033
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.030 |
None |
1.000 |
3 |
|
2000 |
2019 |
Thyroid carcinoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
1175
|
145
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2019 |
Kidney Neoplasm
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
295
|
11
|
0.020 |
None |
1.000 |
2 |
|
2000 |
2004 |
Acute pancreatitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
435
|
51
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Prostate carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4388
|
1168
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
ovarian neoplasm
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2542
|
757
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Malignant neoplasm of ovary
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2563
|
315
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Tubulointerstitial fibrosis
|
phenotype |
|
Disease or Syndrome
|
328
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Secondary Neoplasm
|
group |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2492
|
85
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Renal interstitial fibrosis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Skin and Connective Tissue Diseases; Male Urogenital Diseases
|
Disease or Syndrome
|
138
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Asthma
|
disease |
Respiratory Tract Diseases; Immune System Diseases
|
Disease or Syndrome
|
2096
|
1536
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Malignant neoplasm of thyroid
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
949
|
103
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Thyroid Neoplasm
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
1164
|
135
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Thyroid Nodule
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
150
|
17
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Thyroid Gland Follicular Adenoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
202
|
14
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
pineoblastoma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
18
|
6
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Follicular thyroid carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
293
|
28
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Carcinoma, Ovarian Epithelial
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2841
|
327
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |